Search Results - "Bernard, B F"

Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats by Rolleman, E J, Bernard, B F, Breeman, W A P, Forrer, F, de Blois, E, Hoppin, J, Gotthardt, M, Boerman, O C, Krenning, E P, de Jong, M

“…In peptide receptor radionuclide therapy (PRRT) using radiolabelled somatostatin analogues, kidney uptake of radiolabelled compound is the major dose-limiting…”
Get more information

Tumor Response After [90Y-DOTA0,Tyr3]Octreotide Radionuclide Therapy in a Transplantable Rat Tumor Model Is Dependent on Tumor Size by de Jong, Marion, Breeman, Wout A.P, Bernard, Bert F, Bakker, Willem H, Visser, Theo J, Kooij, Peter P.M, van Gameren, Arthur, Krenning, Eric P

“…A promising application of radiolabeled somatostatin analogs is peptide receptor-targeted radionuclide therapy of somatostatin receptor-expressing tumors. A…”
Get full text

Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy by De Jong, M, Bernard, B F, De Bruin, E, Van Gameren, A, Bakker, W H, Visser, T J, Mäcke, H R, Krenning, E P

“…We compared the internalization of [90Y-DOTA0,Tyr3]octreotide and [111In-DOTA0,Tyr3]octreotide with that of [125I-Tyr3]octreotide and [111In-DTPA0]octreotide…”
Get more information

Pre‐clinical evaluation of [111In‐DTPA‐Pro1, Tyr4]bombesin, a new radioligand for bombesin‐receptor scintigraphy by Breeman, Wout A.P., De Jong, Marion, Bernard, Bert F., Kwekkeboom, Dik J., Srinivasan, Ananth, van der Pluijm, Marcel E., Hofland, Leo J., Visser, Theo J., Krenning, Eric P.

“…Bombesin (BN) is a 14‐amino‐acid neuropeptide with a high affinity for the gastrin‐releasing peptide receptor. This receptor has been found to be expressed in…”
Get full text

D-Lysine Reduction of Indium-111 Octreotide and Yttrium-90 Octreotide Renal Uptake by Bernard, Bert F, Krenning, Eric P, Breeman, Wout A.P, Rolleman, Edgar J, Bakker, Willem H, Visser, Theo J, Macke, Helmut, de Jong, Marion

“…Indium-111-DTPA-octreotide (111In-DTPAOC) is used successfully for imaging somatostatin receptor-positive lesions. A new and promising application is its use…”
Get full text

Pre‐clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor‐targeted scintigraphy and radionuclide therapy by De Jong, Marion, Bakker, Willem H., Breeman, Wout A. P., Bernard, Bert F., Hofland, Leo J., Visser, Theo J., Srinivasan, Ananth, Schmidt, Michelle, Béhé, Martin, Mäcke, Helmut R., Krenning, Eric P.

“…We have evaluated the potential usefulness of radiolabelled [DTPA0,Tyr3]octreotide and [DOTA0,Tyr3]octreotide as radiopharmaceuticals for somatostatin…”
Get full text

Inhibition of Renal Uptake of Indium-111-DTPA-Octreotide In Vivo by de Jong, Marion, Rolleman, Edgar J, Bernard, Bert F, Visser, Theo J, Bakker, Willem H, Breeman, Wout A.P, Krenning, Eric P

“…Indium-111-DTPA-octreotide has been successfully used for imaging of somatostatin receptor-positive lesions. However, significant renal uptake of…”
Get full text

Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount by de Jong, M, Breeman, W A, Bernard, B F, van Gameren, A, de Bruin, E, Bakker, W H, van der Pluijm, M E, Visser, T J, Mäcke, H R, Krenning, E P

“…Radiolabelled tumour receptor-binding peptides can be used for in vivo scintigraphic imaging. Recently, the somatostatin analogue [Tyr3]octreotide…”
Get full text

Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy by BERNARD, B F, KRENNING, E, BREEMAN, W A.P, VISSER, T J, BAKKER, W H, SRINIVASAN, A, DE JONG, M

“…We have evaluated the usefulness of the rat pancreatic CA20948 tumour as an in vitro cell culture model and as an in vivo model in Lewis rats comparing…”
Get full text

A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia by Lim, C F, Bernard, B F, de Jong, M, Docter, R, Krenning, E P, Hennemann, G

“…We studied the effects of 3-carboxy-4-methyl-5-propyl-2-furan-propanoic acid (CMPF), indoxyl sulfate, and hippuric acid on iodide production by rat hepatocytes…”
Get more information

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy by de Jong, M, Bakker, W H, Krenning, E P, Breeman, W A, van der Pluijm, M E, Bernard, B F, Visser, T J, Jermann, E, Béhé, M, Powell, P, Mäcke, H R

“…In vitro octreotide receptor binding of [111In-DOTA0,d-Phe1, Tyr3]octreotide (111In-DOTATOC) and the in vivo metabolism of 90Y- or 111In-labelled DOTATOC were…”
Get full text

Impaired thyroxine and 3,5,3'-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness by Vos, R A, De Jong, M, Bernard, B F, Docter, R, Krenning, E P, Hennemann, G

“…In systemic nonthyroidal illness (NTI), peripheral production of T3 from T4 is decreased, resulting in a decreased serum T3 concentration. We investigated…”
Get more information

Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy by Melis, M, Forrer, F, Capello, A, Bijster, M, Bernard, B F, Reubi, J C, Krenning, E P, De Jong, M

“…Peptide receptor radionuclide therapy using the somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate is a convincing treatment modality for metastasized…”
Get full text

T4 uptake into the perfused rat liver and liver T4 uptake in humans are inhibited by fructose by De Jong, M, Docter, R, Bernard, B F, van der Heijden, J T, van Toor, H, Krenning, E P, Hennemann, G

“…Recently, we described a two-pool model for 3,5,3'-triiodothyronine uptake and metabolism in the isolated perfused rat liver. Here, we applied this model to…”
Get full text

Transport and metabolism of iodothyronines in cultured human hepatocytes by de Jong, M, Visser, T J, Bernard, B F, Docter, R, Vos, R A, Hennemann, G, Krenning, E P

“…Thyroid hormone uptake into cultured human hepatocytes was studied using measurement of cell-associated radioactivity of radioiodinated thyroid hormones after…”
Get more information

Carrier-mediated transport of thyroid hormone into rat hepatocytes is rate-limiting in total cellular uptake and metabolism by Hennemann, G, Krenning, E P, Polhuys, M, Mol, J A, Bernard, B F, Visser, T J, Docter, R

“…We investigated if carrier-mediated transport into rat hepatocytes is rate-limiting in total cellular uptake and metabolism of thyroid hormone. Rat hepatocytes…”
Get more information

Evaluation of radiolabelled bombesin analogues for receptor‐targeted scintigraphy and radiotherapy by Breeman, Wout A.P., Hofland, Leo J., de Jong, Marion, Bernard, Bert F., Sinivasan, Ananth, Kwekkeboom, Dik J., Visser, Theo J., Krenning, Eric P.

“…The 14‐aminoacid peptide bombesin (BN) has a high affinity for the gastrin‐releasing peptide receptor which is expressed by a variety of tumours. Thus,…”
Get full text

Preclinical and Initial Clinical Evaluation of 111In-Labeled Nonsulfated CCK8 Analog: A Peptide for CCK-B Receptor-Targeted Scintigraphy and Radionuclide Therapy by de Jong, Marion, Bakker, Willem H, Bernard, Bert F, Valkema, Roelf, Kwekkeboom, Dik J, Reubi, Jean-Claude, Srinivasan, Ananth, Schmidt, Michelle, Krenning, Eric P

“…The presence of cholecystokinin (CCK)-B (gastrin) receptors has been shown in more than 90% of medullary thyroid cancers (MTCs) and in a high percentage of…”
Get full text

Influence of silver on the catalytic activity of Cu-ZSM-5 for NO SCR by propane. Effect of the presence of water and hydrothermal agings by CHAJAR, Z, DENTON, P, DE BERNARD, F. B, PRIMET, M, PRALIAUD, H

“…The effect of silver on the activity and hydrothermal stability of Cu‐ZSM‐5 for NOχ reduction with C3H8 under oxidizing and wet conditions has been…”
Get full text

Production and characterization of monoclonal and polyclonal antibodies against thyrotropin-releasing hormone by Klootwijk, W, Vaessen, L M, Bernard, B F, Rondeel, J M, De Greef, W J, Visser, T J

“…In this article, two mouse monoclonal antibodies (83-7B5-A1 and 83-6B6-A10) and three rabbit polyclonal antibodies (1118, 8572, and 8577) directed against…”
Get more information